I-Mab
Anti-LAG-3 antibodies and uses thereof
Last updated:
Abstract:
The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.
Status:
Grant
Type:
Utility
Filling date:
22 Feb 2018
Issue date:
3 Mar 2020